Top entities: Savara, Bob Lutz, Dave Lowrance, Matt Pauls, iBio.

What category does this event fall under?

Business — classified as executive change.

What is the sentiment of coverage?

Aggregate sentiment score: 10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This event is archived — the story has concluded and this page is a final snapshot.

Business executive change

Savara CFO Dave Lowrance Steps Down

Q: When did this event occur?

First reported Jun 08, 2026; last updated Jun 08, 2026.

Q: What is the market impact?

General. The market impact on Savara is likely neutral to slightly positive, as the company is ensuring a smooth leadership transition with an experienced internal candidate, Bob Lutz, taking on the CFO role.

Analysis based on 7 articles · First reported Jun 08, 2026 · Last updated Jun 08, 2026

Sentiment

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The market impact on Savara is likely neutral to slightly positive, as the company is ensuring a smooth leadership transition with an experienced internal candidate, Bob Lutz, taking on the CFO role. While the departure of a long-serving CFO like Dave Lowrance could introduce uncertainty, the company's proactive communication and the appointment of a qualified successor mitigate potential negative sentiment.

biopharmaceutical

Event Summary

Savara Inc. announced that Dave Lowrance, its Chief Financial and Administrative Officer, is stepping down from his role effective July 15, 2026, due to health reasons. Dave Lowrance has been with Savara for nearly ten years, guiding the company through significant milestones including capital raises and its Nasdaq-100 listing. Bob Lutz, currently Savara's Chief Operating Officer, will assume the additional role of Chief Financial Officer. The administrative responsibilities previously held by Dave Lowrance will be distributed among the senior leadership team. Matt Pauls, Savara's CEO, expressed gratitude for Dave Lowrance's contributions and confidence in Bob Lutz's ability to ensure a seamless transition and continued strong financial stewardship.

Entities Involved

stock

Savara

Savara announced a transition in its Chief Financial and Administrative Officer role, with Dave Lowrance stepping down and Bob Lutz assuming the CFO position. This change aims to ensure continued strong financial stewardship and operational leadership for the company.

Importance 100.0 Sentiment 10.0

per

Bob Lutz

Bob Lutz, currently Chief Operating Officer of Savara, will assume the additional role of Chief Financial Officer. His expanded role is expected to ensure a seamless transition and continued strong financial stewardship for Savara.

Importance 90.0 Sentiment 20.0

per

Dave Lowrance

Dave Lowrance is stepping down as Chief Financial and Administrative Officer of Savara for health-related reasons after nearly ten years of service. He will remain available in an advisory capacity.

Importance 80.0 Sentiment 0.0

per

Matt Pauls

Matt Pauls, Chair and CEO of Savara, expressed gratitude for Dave Lowrance's contributions and confidence in Bob Lutz's ability to take on the expanded CFO role.

Importance 40.0 Sentiment 0.0

stock

iBio

Bob Lutz previously served as Chief Financial and Business Officer of iBio, Inc., prior to joining Savara.